Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555905 · ClinicalTrials.gov registry record · NA
Respiratory Muscle Strength in Patients With NMD
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01555905: Clinical Trial NA study, sponsored by University of Florida.
NCT01555905 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01555905, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.
Primary Outcome
The primary endpoints for inspiratory muscle training efficacy will be maximal inspiratory pressure tests, a measure of respiratory strength.
Interventions
- DEVICE Threshold PEP or IMT device Phillips-Respironics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-04 |
| Est. Completion | 2022-03 |
| Phase | NA |
Why NCT01555905 stopped before completion
NCT01555905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Threshold PEP or IMT device Phillips-Respironics is the first listed.
NCT01555905 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01555905 about?
NCT01555905 is a clinical study titled "Respiratory Muscle Strength in Patients With NMD". The purpose of this study is to determine if inspiratory muscle strength training (IMST) will impact maximal inspiratory pressure and pulmonary function in patients with neuromuscular disease.
What is the current status of trial NCT01555905?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2011-04. Estimated completion is 2022-03.
What interventions are being tested in trial NCT01555905?
The interventions under investigation include: Threshold PEP or IMT device Phillips-Respironics (DEVICE).
Who is sponsoring clinical trial NCT01555905?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01555905's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia